Page last updated: 2024-08-26

rhodomycinone and Carcinoma, Small Cell

rhodomycinone has been researched along with Carcinoma, Small Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demant, EJ; Friche, E; Hansen, HH; Jensen, PB; Kjeldsen, E; Sehested, M; Sørensen, BS1

Other Studies

1 other study(ies) available for rhodomycinone and Carcinoma, Small Cell

ArticleYear
Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance.
    Biochemical pharmacology, 1993, May-25, Volume: 45, Issue:10

    Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Carcinoma, Small Cell; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leukemia L1210; Lung Neoplasms; Mice; Naphthacenes; Stimulation, Chemical; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1993